US Universities Contributed 87 Percent of Academic Patents for FDA-Approved Drugs Between 2020 and 2024

Between 2020 and 2024, universities played a significant role in the development of FDA-approved drugs, contributing patents that supported half of all such approvals during this period. A detailed analysis revealed that 87% of these academic contributions originated from institutions based in the United States.

The findings highlight the substantial involvement of American universities in pharmaceutical innovation. Researchers examined data related to drug patents listed in the FDA’s Orange Book, which tracks intellectual property tied to approved medications. The study identified that U.S.-based academic institutions were responsible for the majority of groundbreaking discoveries, underscoring their influence on advancements in medicine. This research sheds light on the critical role academia plays in driving progress within the pharmaceutical sector.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: June 6, 2025

Author

Mark Chiang